Swedencare (SECARE) CMD 2026 summary
Event summary combining transcript, slides, and related documents.
CMD 2026 summary
10 Jun, 2026Strategic direction and market trends
Focus on global expansion through organic growth and acquisitions, with 14 company acquisitions since June 2020 and presence in over 70 countries.
Emphasis on non-prescriptive animal health products, pet supplements, functional treats, and pharmaceuticals, targeting both veterinary and retail/online channels.
Channel strategy prioritizes eCommerce and D2C, leveraging influencer marketing, social media, and tailored digital marketing, with Amazon and Walmart as key growth engines.
Pet supplement market expected to double by 2030, driven by pet humanization, premiumization, and rising spend per pet.
Product innovation targets both dogs and cats, with new formats, palatability improvements, and fast-track launches from idea to market in 8–12 weeks.
Operational initiatives and production expansion
Manufacturing footprint expanded to six operations in four countries, supporting supplements, functional treats, liquids, and pharma solids.
Two major production expansions underway in North America and Canada, targeting sterile drugs, treats, and Rx liquids.
Vetio brand maintains 72% of revenue from external customers, ensuring competitiveness and scale.
New facilities in Florida and Montreal will enable production of a broader range of dosage forms, including sterile liquids.
SummitVet in the UK is pioneering soft chew dosage forms for veterinary pharmaceuticals.
Brand and channel development
ProDen PlaqueOff remains the flagship brand, achieving 10x revenue growth in 10 years and 29% organic growth last year.
Veterinary channel strengthened by private label strategies and exclusive product lines for vets.
NaturVet brand refreshed, expanded into major US retailers, and enhanced marketing efforts.
E-commerce dominates US supplement sales, with Amazon and Walmart as key growth drivers.
Innovation pipeline includes cat-specific products and human-inspired supplement formats, with award-winning launches like ProDen PlaqueOff Cat Crème.
Latest events from Swedencare
- Double-digit organic growth and record gross margin highlight a strong start to 2026.SECARE
Q1 202623 Apr 2026 - Q4 organic growth was strong, but one-off costs pressured margins; recovery expected in 2026.SECARE
Q4 202510 Apr 2026 - Improved margins and strong sales drive a positive outlook as operational challenges ease.SECARE
Pre-close call20 Mar 2026 - Q2 revenue up 10% with margin gains, strong European growth, and strategic acquisitions.SECARE
Q2 20243 Feb 2026 - Q3 saw 9% organic growth, higher margins, and strong European and dental segment gains.SECARE
Q3 202419 Jan 2026 - Q3 2025 saw record growth, robust margins, and new targets for global expansion and profitability.SECARE
SEB Nordic Seminar presentation16 Jan 2026 - Q1 2025 delivered 7% revenue growth, strong cash flow, and key acquisitions for future expansion.SECARE
Q1 202523 Dec 2025 - Record sales and margins in 2024, with Europe and dental segments leading growth; NaturVet set for 2025 rebound.SECARE
Q4 202417 Dec 2025 - Record Q3 revenue and profitability, led by strong organic growth and U.S. retail expansion.SECARE
Q3 202514 Dec 2025